These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 23517067)
21. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
22. Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles. Sahin A; Spiroux F; Guedon I; Arslan FB; Sarcan ET; Ozkan T; Colak N; Yuksel S; Ozdemir S; Ozdemir B; Akbas S; Ultav G; Aktas Y; Capan Y Pharmazie; 2017 Sep; 72(9):525-528. PubMed ID: 29441979 [TBL] [Abstract][Full Text] [Related]
23. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X; Zou W; Liu C; Zhang N; Fu C Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [TBL] [Abstract][Full Text] [Related]
24. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity. Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812 [TBL] [Abstract][Full Text] [Related]
25. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability. Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038 [TBL] [Abstract][Full Text] [Related]
26. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions. Liu SQ; Tong YW; Yang YY Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542 [TBL] [Abstract][Full Text] [Related]
27. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859 [TBL] [Abstract][Full Text] [Related]
28. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Nair K L; Jagadeeshan S; Nair SA; Kumar GS Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233 [TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
30. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655 [TBL] [Abstract][Full Text] [Related]
31. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y; Xie XY; Mei XG Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204 [TBL] [Abstract][Full Text] [Related]
32. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815 [TBL] [Abstract][Full Text] [Related]
35. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381 [TBL] [Abstract][Full Text] [Related]
36. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Zeng P; Xu Y; Zeng C; Ren H; Peng M Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597 [TBL] [Abstract][Full Text] [Related]
37. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382 [TBL] [Abstract][Full Text] [Related]
38. Polymeric nanoparticles for siRNA delivery and gene silencing. Patil Y; Panyam J Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242 [TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. Maji R; Dey NS; Satapathy BS; Mukherjee B; Mondal S Int J Nanomedicine; 2014; 9():3107-18. PubMed ID: 25028549 [TBL] [Abstract][Full Text] [Related]
40. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]